Details for Patent: 8,936,777
✉ Email this page to a colleague
Which drugs does patent 8,936,777 protect, and when does it expire?
Patent 8,936,777 protects FLYRCADO and is included in one NDA.
This patent has fifty patent family members in nineteen countries.
Drugs Protected by US Patent 8,936,777
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ge Hlthcare | FLYRCADO | flurpiridaz f-18 | SOLUTION;INTRAVENOUS | 215168-001 | Sep 27, 2024 | RX | Yes | Yes | 8,936,777 | ⤷ Subscribe | METHOD OF POSITRON EMISSION TOMOGRAPHY (PET) FOR CARDIAC IMAGING | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,936,777
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2011213568 | ⤷ Subscribe | |||
Australia | 2016213781 | ⤷ Subscribe | |||
Australia | 2018201916 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |